Angiotensin II (AT-II)-Receptor Antagonists are Reviewed. Research focused on blocking the renin- angiotensin system (RAS) led to the discovery of angiotensin-converting-enzyme (ACE) inhibitors ...
Results of the largest clinical trials in patients with T2DM and advanced diabetic nephropathy demonstrated that blockade of the renin–angiotensin system led to a smaller reduction in the risk ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback